← All trials
NCT04769037
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 22, 2021
- Primary completion
- Oct 31, 2027
- Completion date
- Oct 31, 2027
- First posted
- Feb 24, 2021
- Last posted
- Oct 7, 2021
- Enrollment
- 1144
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Helmholtz Centre for Infection ResearchLead sponsor
- Lund UniversityCollaborator
- Technical University of DresdenCollaborator
- Katholieke Universiteit LeuvenCollaborator
- Technical University of MunichCollaborator
- Gottfried Wilhelm Leibniz Universität HannoverCollaborator
- Medical University of WarsawCollaborator
- Helmholtz Centre for Infection ResearchReponsible party - principal investigator
- Royal Victoria Infirmary, Newcastle upon Tyne, UKCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.